Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis Faeze Eskandari a , Ghazal Alipour Talesh a , Maryam Parooie a , Mahmoud Reza Jaafari b,1 , Ali Khamesipour c , Zahra Saberi a , Azam Abbasi a , Ali Badiee a, * ,1 a Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran b Biotechnology Research Center, Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran c Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran H I G H L I G H T S Development of new generation of vaccines against leishmaniasis requires adjuvants. Immunoliposome as an adjuvant was prepared by grafting IgG onto liposomal surface. Immunoliposome induced stronger cell mediated immunity compared with liposome. G R A P H I CA L A B ST R AC T ARTICLE INFO Article history: Received 9 November 2013 Received in revised form 9 June 2014 Accepted 26 August 2014 Available online 20 September 2014 Keywords: Vaccine Immunoliposomes SLA Leishmaniasis A B ST R AC T Development of new generation of vaccines against leishmaniasis requires adjuvants to elicit the type and intensity of immune response needed for protection. The coupling of target-specific antibodies to the liposomal surface to create immunoliposomes has appeared as a promising way in achieving a li- posome active targeting. In this study, immunoliposomes were prepared by grafting non-immune mouse IgG onto the liposomal surface. The influence of active targeted immunoliposomes on the type and in- tensity of generated immune response against Leishmania was then investigated and compared with that of liposomes and control groups which received either SLA or HEPES buffer alone. All formulations con- tained SLA and were used to immunize the mice in the left hind footpad three times in 3-week intervals. Evaluation of lesion development and parasite burden in the foot and spleen after challenge with Leish- mania major, evaluation of Th1 cytokine (IFN-γ), and titration of IgG isotypes were carried out to assess the type of generated immune response and the extent of protection. The results indicated that lipo- somes might be effective adjuvant systems to induce protection against L. major challenge in BALB/c mice, but stronger cell mediated immune responses were induced when immunoliposomes were utilized. Thus, immune modulation using immunoliposomes might be a practical approach to improve the immuniza- tion against L. major. © 2014 Elsevier Inc. All rights reserved. * Corresponding author. Fax: +98 511 8823251. E-mail address: badieea@mums.ac.ir (A. Badiee). 1 A.B. and M.R.J. equally designed this research. http://dx.doi.org/10.1016/j.exppara.2014.08.016 0014-4894/© 2014 Elsevier Inc. All rights reserved. Experimental Parasitology 146 (2014) 78–86 Contents lists available at ScienceDirect Experimental Parasitology journal homepage: www.elsevier.com/locate/yexpr